editorialJournal of Medicinal ChemistryJul 24, 2025GREEN OA

NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders

ZMZonghui MaJZJia Zhou

The University of Texas Medical Branch at Galveston

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

44
total citations
FWCI
27.11
Percentile
100%
References
43
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Chemistry
No related works found for this paper.

Funding